March 04, 2008
Image of Lisdexamfetamine

Lisdexamfetamine—trade name Vyvanse—is amphetamine coupled with l-lysine. It is being developed to treat attention-deficit hyperactivity disorder (ADHD) in pediatric patients. It provides controlled release of amphetamine via hydrolysis within the body and decreases the potential for abuse because crushing the capsule does not accelerate its activation.

Chemical Abstract Service - a division of ACS

Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.

Molecule of the Week needs your suggestions!

If your favorite molecule is not in our archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!

Stay Ahead of the Chemistry Curve

Learn how ACS can help you stay ahead in the world of chemistry.